# Zai Lab Ltd: Form D filing

Zai Lab Ltd, a biotechnology company in Cambridge, MA, filed a Form D with the SEC in 2026. The latest, on November 9, 2026, reports $249.9 million sold of a $249.9 million offering to 25 investors.

Find out what Zai Lab Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Zai%20Lab%20Ltd%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Zai%20Lab%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fzai-lab-ltd-1704292)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Zai%20Lab%20Ltd%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Zai%20Lab%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fzai-lab-ltd-1704292)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 314 MAIN STREET 4TH FLOOR, SUITE 10, Cambridge, MA, 02142
- Phone: +1 857 706 2604
- Industry: Biotechnology
- Entity type: Other
- Incorporated in: Cayman Islands
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1704292

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| [Nov 9, 2026](https://specstream.ai/data/form-d/day/2026-11-09) | New notice | $249,933,600 | $249,933,600 | $0 | 25 | Oct 27, 2026 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1704292/000170429226000038/0001704292-26-000038-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| SAMANTHA (YING) DU, Ph.D. | Executive Officer, Director |  |
| JOHN DAVID DIEKMAN, Ph.D. | Director |  |
| RICHARD BRIAN GAYNOR, M.D. | Director |  |
| NISA BERNICE WING-YU LEUNG | Director |  |
| WILLIAM DAVID LIS | Director |  |
| SCOTT WILLIAM MORRISON | Director |  |
| LEON OLIVER MOULDER, JR. | Director |  |
| MICHEL PERICLES VOUNATSOS | Director |  |
| PETER KARL WIRTH, J.D. | Director |  |
| YAJING CHEN, Ph.D. | Executive Officer |  |
| RAFAEL G. AMADO, M.D. | Executive Officer |  |
| F. TY EDMONDSON, J.D. | Executive Officer |  |

## Other biotechnology companies in Massachusetts that filed recently

- [AI3 Bio, Inc.](https://specstream.ai/data/form-d/company/ai3-bio-inc-2019875) offering · Nov 4, 2026
- [Tru Singular Health, Inc.](https://specstream.ai/data/form-d/company/tru-singular-health-inc-2158834) $1 million · Oct 30, 2026
- [511 Therapeutics, Inc.](https://specstream.ai/data/form-d/company/511-therapeutics-inc-1946264) $500,000 · Oct 30, 2026
- [Elucid Bioimaging Inc.](https://specstream.ai/data/form-d/company/elucid-bioimaging-inc-1585931) $56.2 million · Oct 27, 2026
- [OrthoIQ, Inc.](https://specstream.ai/data/form-d/company/orthoiq-inc-2154488) $1.1 million · Oct 23, 2026
- [LeanBio Therapeutics, Inc.](https://specstream.ai/data/form-d/company/leanbio-therapeutics-inc-2160802) offering · Oct 22, 2026

[Every Form D from the week of Nov 9, 2026](https://specstream.ai/data/form-d/week/2026-11-09) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Zai Lab Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).